Institutions added $3.1B while insiders fled, creating record divergence as margins hit decade lows at 36x earnings.
The pendulum has swung to optimism pricing in a recovery that the fundamentals don't yet support, while insiders who know the cycle best are quietly exiting.
Is the price above or below what the business is worth?
This framework sees price dramatically exceeding value. The market is paying growth multiples for a business in decline, requiring a 12.7 percentage point swing from current trajectory to justify valuation. Classic first-level thinking — good company, let's buy — without considering the price paid.
Where is sentiment — at euphoria, despair, or somewhere between?
The pendulum has swung firmly toward optimism. Institutional money is flooding in at the fastest pace on record, creating a crowded trade. When sophisticated investors all rush the same direction this quickly, it often marks sentiment extremes.
Where are we in the cycle?
Multiple metrics signal we're past the cycle peak and deteriorating. Margins, growth, and returns on capital all peaked simultaneously and are now in synchronized decline. The cycle is telling us to be cautious, not euphoric.
What does everyone believe, and where might they be wrong?
First-level sees pricing power and assumes margin recovery. Second-level recognizes that pricing gains of 5.6% couldn't prevent gross margins from hitting decade lows — costs are rising faster than prices. The asymmetric earnings reactions reveal a market positioned for perfection in a deteriorating business.
This framework sees a pendulum that has swung too far toward optimism. The price embeds growth assumptions that conflict with deteriorating fundamentals, while those closest to the business vote with their feet. Marks teaches that risk is highest when everyone believes it's lowest — and institutional euphoria at cycle lows often marks that moment. Is this the bottom of the cycle or just another step down?
This analysis applies Howard Marks's published investment framework to publicly available financial data. It is not authored by, endorsed by, or affiliated with Howard Marks. Educational purposes only. Not financial advice.